Anzitor

Anzitor® EZ

/in , /by
Anzitor

Atorvastatin & Ezetimibe
Cholesterol & TG regulators (Cardiovascular Preparations)

Indication:

• Primary Hyperlipidemia
• Homozygous Familial Hypercholesterolemia

Dosage & Administration:

The dosage range of Anzitor® EZ is 10/10 mg/day to 80/10 mg/day. The recommended starting dose of Anzitor® EZ is 10/10 mg/day or 20/10 mg/day. Anzitor® EZ can be administered as a single dose at any time of the day, with or without food. The recommended starting dose for patients who require a larger reduction in LDL-C (greater than 55%) is 40/10 mg/day. After initiation and/or upon titration of Anzitor® EZ, lipid levels should be analyzed within 2 or more weeks and dosage adjusted accordingly.
Patients should swallow Anzitor® EZ tablet whole. Tablets should not be crushed, dissolved, or chewed.
The dosage of Anzitor® EZ in patients with homozygous familial hypercholesterolemia is 10/40 mg/day or 10/80 mg/day. Anzitor® EZ should be used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) in these patients or if such treatments are unavailable.

Preparation:

Anzitor® EZ 10/10: Each box contains 30 tablets in Alu-Alu blister pack.
Anzitor® EZ 20/10: Each box contains 30 tablets in Alu-Alu blister pack.